Lindsay Pike
Associate
UK Patent Attorney
BSc, PhD, PGCert, CPA
UK Patent Attorney
BSc, PhD, PGCert, CPA
Lindsay has been a member of the life sciences and chemistry team at Mathys & Squire since September 2021, having previously worked at another private practice firm. She has technical knowledge across a wide range of technologies, including antibodies, CAR-T cells, gene therapy, microbial-based inventions such as probiotics, and genetically-modified plants.
Expertise
Lindsay has experience in patent drafting, prosecution and opposition of patent applications in the UK, Europe and worldwide. She has worked on cases from a variety of clients, including multinational companies, SMEs and academic institutions, across the chemical and pharmaceutical fields. She has particular experience in antibodies, chimeric antigen receptors, gene therapies, vaccines and genetically modified microorganisms.
Lindsay dual-qualified as a UK and European Patent Attorney in 2023. She was awarded the Ballantyne Prize by the UK Chartered Institute of Patent Attorneys for the highest mark in the Validity & Infringement (FD4/P6) final examination.
Academic
Lindsay has studied human, microbial and plant genetics as part of her BSc genetics at Cardiff University (2015), when she also gained experience in rare plant genetics research for conservation purposes at the Royal Botanic Gardens, Kew, London. She then completed a PhD in microbiology and genomics at the University of Cambridge (2020), and a PGCert in Intellectual Property Law at Queen Mary University of London (2021).
Her doctoral research involved identifying novel bacteria and antibiotic resistance genes from the intestinal microbiome.
Memberships & organisations
Lindsay is a member of the Chartered Institute of Patent Attorneys (CIPA) and the European Patent Institute (EPI).
